SINGAPORE, Feb. 3 (CNA) - The Health Sciences Authority (HSA) has granted interim authorisation for Moderna's COVID-19 vaccine to be used in Singapore for people aged 18 years and above, it announced on Wednesday (Feb 3).
The vaccination regime submitted by Moderna requires two doses of the vaccine to be administered 28 days apart.
"HSA’s review of the available clinical data found that the benefits of the Moderna COVID-19 vaccine outweigh the known risks," said the agency in a press release.
"The vaccine demonstrated a high vaccine efficacy of 94 per cent."
The first shipment is expected to arrive around March, said the Ministry of Health (MOH).
Moderna's COVID-19 vaccine is the second vaccine to be granted interim authorisation under the Pandemic Special Access Route (PSAR).